Zobrazeno 1 - 10
of 78
pro vyhledávání: '"Akira Takazawa"'
Autor:
Akira Takazawa, Yasuo Yoshimura, Masanori Okamoto, Atsushi Tanaka, Munehisa Kito, Kaoru Aoki, Takeshi Uehara, Jun Takahashi, Hiroyuki Kato, Jun Nakayama
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-8 (2023)
Abstract Myxoid liposarcoma (MLS) is a common subtype of liposarcoma. Although the prognosis is generally good, there are factors known to be associated with poor prognosis. Accurate indices are important to predict prognosis. We aimed to assess the
Externí odkaz:
https://doaj.org/article/a8e415856e964192bc4b604985ec2c05
Autor:
Masanori Okamoto, Akira Takazawa, Kaoru Aoki, Yasuo Yoshimura, Hiroyuki Kato, Toshiaki Otsuki, Kazuma Maeno, Tomonobu Koizumi
Publikováno v:
World Journal of Surgical Oncology, Vol 15, Iss 1, Pp 1-5 (2017)
Abstract Background Single soft tissue metastasis of medullary thyroid carcinoma is extremely rare. In addition, several occult medullary thyroid carcinomas with distant metastasis were reported, but undetectable primary lesion at diagnosis was also
Externí odkaz:
https://doaj.org/article/2cd91904838146698414a65b33788a7f
Autor:
Nobuhito Araki, Yasuo Yoshimura, Tetsuhiko Mimura, Atsushi Tanaka, Kenji Sano, Akira Takazawa, Kaoru Aoki, Shuichiro Suzuki, Masanori Okamoto, Munehisa Kito
Publikováno v:
Journal of Orthopaedic Science. 27:1359-1362
Autor:
Atsushi Tanaka, Masanori Okamoto, Munehisa Kito, Yasuo Yoshimura, Kaoru Aoki, Shuichiro Suzuki, Akira Takazawa, Yukiko Komatsu, Hirokazu Ideta, Takaaki Ishida, Jun Takahashi
Publikováno v:
International Journal of Clinical Oncology.
Autor:
Yuko Kitagawa, Akira Takazawa, Yasuhiro Matsumura, Ioannis Xynos, Eva Holtved, Chih-Hung Hsu, Sung-Bae Kim, Yutaro Kubota, Chueh-Chuan Yen, Yuichiro Doki, Yasuo Hamamoto, Myung-Ju Ahn, Shigenori Kadowaki, Keisho Chin, Chen-Yuan Lin, Masanobu Takahashi, Byoung Chul Cho, Ken Kato, Morihito Okada
Supplementary Data from Three-Year Follow-Up and Response–Survival Relationship of Nivolumab in Previously Treated Patients with Advanced Esophageal Squamous Cell Carcinoma (ATTRACTION-3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::012c9054275c23855ab7b1aee7171098
https://doi.org/10.1158/1078-0432.22483407
https://doi.org/10.1158/1078-0432.22483407
Autor:
Yuko Kitagawa, Akira Takazawa, Yasuhiro Matsumura, Ioannis Xynos, Eva Holtved, Chih-Hung Hsu, Sung-Bae Kim, Yutaro Kubota, Chueh-Chuan Yen, Yuichiro Doki, Yasuo Hamamoto, Myung-Ju Ahn, Shigenori Kadowaki, Keisho Chin, Chen-Yuan Lin, Masanobu Takahashi, Byoung Chul Cho, Ken Kato, Morihito Okada
Supplementary Table from Three-Year Follow-Up and Response–Survival Relationship of Nivolumab in Previously Treated Patients with Advanced Esophageal Squamous Cell Carcinoma (ATTRACTION-3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::59b290bf57cedce0e34902700423d351
https://doi.org/10.1158/1078-0432.22483389.v1
https://doi.org/10.1158/1078-0432.22483389.v1
Autor:
Yuko Kitagawa, Akira Takazawa, Yasuhiro Matsumura, Ioannis Xynos, Eva Holtved, Chih-Hung Hsu, Sung-Bae Kim, Yutaro Kubota, Chueh-Chuan Yen, Yuichiro Doki, Yasuo Hamamoto, Myung-Ju Ahn, Shigenori Kadowaki, Keisho Chin, Chen-Yuan Lin, Masanobu Takahashi, Byoung Chul Cho, Ken Kato, Morihito Okada
Purpose:Limited long-term data are available on immune checkpoint inhibitor use in patients with advanced esophageal squamous cell carcinoma (ESCC). We report 3-year follow-up data from our study of nivolumab versus chemotherapy (paclitaxel or doceta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70bb54d97abc90463cdf2667b9770daf
https://doi.org/10.1158/1078-0432.c.6531132.v1
https://doi.org/10.1158/1078-0432.c.6531132.v1
Autor:
Morihito Okada, Ken Kato, Byoung Chul Cho, Masanobu Takahashi, Chen-Yuan Lin, Keisho Chin, Shigenori Kadowaki, Myung-Ju Ahn, Yasuo Hamamoto, Yuichiro Doki, Chueh-Chuan Yen, Yutaro Kubota, Sung-Bae Kim, Chih-Hung Hsu, Eva Holtved, Ioannis Xynos, Yasuhiro Matsumura, Akira Takazawa, Yuko Kitagawa
Publikováno v:
Clinical Cancer Research. 28:3277-3286
Purpose: Limited long-term data are available on immune checkpoint inhibitor use in patients with advanced esophageal squamous cell carcinoma (ESCC). We report 3-year follow-up data from our study of nivolumab versus chemotherapy (paclitaxel or docet
Autor:
Munehisa Kito, Kaoru Aoki, Masanori Okamoto, Akira Takazawa, Jun Takahashi, Atsushi Tanaka, Shuichiro Suzuki, Yasuo Yoshimura
Publikováno v:
Journal of Orthopaedic Science. 27:229-234
To assess the points of consideration when performing surgical procedures for proximal femoral bone metastasis.Fourty patients who underwent surgery for proximal femoral bone metastasis from 2009 to 2019 were included. Prognostic assessments were per
Autor:
Atsushi Tanaka, Masanori Okamoto, Munehisa Kito, Yasuo Yoshimura, Kaoru Aoki, Shuichiro Suzuki, Akira Takazawa, Yukiko Komatsu, Takaaki Ishida, Jun Takahashi
Publikováno v:
Japanese Journal of Clinical Oncology. 52:370-374
Objective To predict the muscle strength and postoperative function for soft-tissue sarcoma arising from the adductor compartment of the thigh. Methods Between 2003 and 2019, 17 cases that underwent resection of the adductor muscle group (adductor lo